SCHEMBL6450450

SCHEMBL6450450

COc1cc2c(cc1OC)[C@@H]1CCCC[C@@H]1N=C2c1ccc(C)s1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 8/20 0.38
PDE4A P27815 7/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
CHRM1 P11229 1/20 0.36
PDE3A Q14432 1/20 0.36
PDE4B Q07343 6/20 0.35
PDE4C Q08493 6/20 0.35
ALDH1A1 P00352 4/20 0.32
KDM4E B2RXH2 3/20 0.32
LMNA P02545 3/20 0.32
ERN1 O75460 1/20 0.32
DNMT1 P26358 1/20 0.32
EHMT2 Q96KQ7 1/20 0.32
TNKS O95271 1/20 0.31
TNKS2 Q9H2K2 1/20 0.31
TSHR P16473 2/20 0.31
MAPK1 P28482 2/20 0.31
NPSR1 Q6W5P4 2/20 0.31
USP2 O75604 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6450454 1.00 PDE4D (0.38) PDE4DPDE4AMEN1KMT2ACHRM1
SCHEMBL6450452 1.00 PDE4D (0.38) PDE4DPDE4AMEN1KMT2ACHRM1
SCHEMBL6449710 0.82 RPS6KB2 (0.41) PDE4DMEN1KMT2AALDH1A1KDM4E
SCHEMBL6449709 0.82 RPS6KB2 (0.41) PDE4DMEN1KMT2AALDH1A1KDM4E
SCHEMBL6449706 0.82 RPS6KB2 (0.41) PDE4DMEN1KMT2AALDH1A1KDM4E
SCHEMBL6442363 0.81 S1PR1 (0.39) PDE4DMEN1KMT2ACHRM1ALDH1A1
SCHEMBL6442355 0.81 S1PR1 (0.39) PDE4DMEN1KMT2ACHRM1ALDH1A1
SCHEMBL6442359 0.81 S1PR1 (0.39) PDE4DMEN1KMT2ACHRM1ALDH1A1
SCHEMBL6453982 0.78 PDE4D (0.40) PDE4DPDE4AMEN1KMT2ACHRM1
SCHEMBL6453986 0.78 PDE4D (0.40) PDE4DPDE4AMEN1KMT2ACHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6884802-B2 6-heteroarylphenanthridines ALTANA PHARMA AG (DE) 2005-04-26 US disclosed
US-20040038979-A1 Treating airway disorders such as asthma. ALTANA PHARMA AG (DE) 2004-02-26 US disclosed
EP-1303506-A1 6-HETEROARYLPHENANTHRIDINES Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 2003-04-23 EP disclosed
WO-2002006270-A1 NOVEL 6-HETEROARYLPHENANTHRIDINES ALTANA PHARMA AG (DE) 2002-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040038979-A1 Treating airway disorders such as asthma. PTGER4, PDE4B, PDE4A PDE4D 20/4885PDE4A 3/4885MEN1 4313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.